Platelet-dependent mechanisms for excessive clotting and bleeding in CKD remain
undefined. Moreover, platelets' contribution to inflammation, and specifically to CKD, are …

Continuous blood purification technology such as hemodiafiltration has been used
worldwide for saving patients suffering from severe diseases or organ function failure …

Background To improve outcomes, simple screening tests are required to detect patients at
increased risk of mortality. As patients with muscle weakness and wasting are at increased …

Objective Muscle wasting is associated with increased mortality and is commonly reported in
dialysis patients. Hemodialysis (HD) and peritoneal dialysis (PD) treatments lead to protein …

Introduction Severe COVID‐19 infections increase the risk of thrombotic events and
Intensive Care Units reported increased extracorporeal circuit clotting (ECC) in COVID‐19 …

Unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs) are commonly
used to prevent clotting of the hemodialysis extracorporeal circuit and optimize hemodialysis …

Introduction Systemic anticoagulation is administered during hemodialysis to prevent
clotting of the extracorporeal circuit. The role of contact system activation in thrombin …

Background: Both frailty and cachexia increase mortality in haemodialysis (HD) patients.
The clinical frailty score (CFS) is a seven-point scale and less complex than other cachexia …

Background During continuous renal replacement therapy (CRRT), anticoagulants are
recommended for patients at low risk of bleeding and not already receiving systemic …

Background Haemodialysis (HD) patients may suffer symptoms during dialysis and take time
to recover post HD. We wished to determine whether patients with symptomatic intra-dialytic …